Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hisato Kawakami
Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI
Oncogenesis
Cancer Research
Molecular Biology
Related publications
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View Beyond Cetuximab
Chemotherapy Research and Practice
Heregulin and HER3 Are Prognostic Biomarkers in Oropharyngeal Squamous Cell Carcinoma
Cancer
Cancer Research
Oncology
Switching From First or Second Generation EGFR-TKI to Osimertinib in EGFR Mutation-Positive NSCLC
Lung Cancer Management
Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated With Inactivation of SH3GL2 and CDC25A Genes
PLoS ONE
Multidisciplinary
Detection of EGFR- And HER2-activating Mutations in Squamous Cell Carcinoma Involving the Head and Neck
Modern Pathology
Forensic Medicine
Pathology
When Is Chemotherapy in Head and Neck Squamous Cell Carcinoma Not Indicated?
European Archives of Oto-Rhino-Laryngology
Medicine
Otorhinolaryngology
Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer
British Journal of Cancer
Cancer Research
Oncology
